Kenneth Huttner Selected Research

Interleukins

5/2014	Pro-inflammatory interleukin-1 genotypes potentiate the risk of coronary artery disease and cardiovascular events mediated by oxidized phospholipids and lipoprotein(a).
1/2009	Interleukin 1 gene cluster, myocardial infarction at young age and inflammatory response of human mononuclear cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth Huttner Research Topics

Disease

6	Anhidrotic Ectodermal Dysplasia 1 10/2020 - 06/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 05/2014 - 03/2008
2	Myocardial Infarction 05/2014 - 01/2009
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 10/2020
1	Glaucoma 01/2018
1	Hyperemia 01/2018
1	Ocular Hypertension (Glaucoma, Suspect) 01/2018
1	Eczema 02/2015
1	Pathologic Constriction (Stenosis) 05/2014
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2014
1	Stroke (Strokes) 05/2014
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2014
1	Xerostomia 01/2014
1	Asthma (Bronchial Asthma) 08/2013
1	Dry Eye Syndromes (Dry Eye Syndrome) 08/2013
1	Atherosclerosis 03/2008

Drug/Important Bio-Agent (IBA)

4	EctodysplasinsIBA 10/2020 - 07/2013
2	Biomarkers (Surrogate Marker)IBA 02/2015 - 06/2011
2	InterleukinsIBA 05/2014 - 01/2009
2	Interleukin-1 (Interleukin 1)IBA 05/2014 - 01/2009
1	Proteins (Proteins, Gene)FDA Link 10/2020
1	MGV354IBA 01/2018
1	hydroxide ionIBA 01/2018
1	Soluble Guanylyl CyclaseIBA 01/2018
1	Lipoprotein(a)IBA 05/2014
1	Biological ProductsIBA 05/2014
1	1-penicillamyl-Leu(2)- oxytocinIBA 05/2014
1	Phospholipids (Phosphatides)FDA LinkGeneric 05/2014
1	Apolipoproteins B (ApoB)IBA 05/2014
1	Artificial SalivaIBA 01/2014
1	4-O-carboxymethylascochlorinIBA 08/2013
1	Thromboplastin (Tissue Factor)IBA 01/2009
1	LipopolysaccharidesIBA 01/2009
1	CoagulantsIBA 01/2009
1	Interleukin-6 (Interleukin 6)IBA 03/2008

Therapy/Procedure

1	Therapeutics 12/2014
1	Radiotherapy 01/2014